Clinical Trials Logo

Cancers, Pain clinical trials

View clinical trials related to Cancers, Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01043068 Completed - Cancers, Pain Clinical Trials

The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

Start date: January 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.

NCT ID: NCT00904280 Completed - Lower Back Pain Clinical Trials

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Start date: March 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of oxymorphone ER as an analgesic in cancer and lower back pain subjects having chronic moderate to severe pain.

NCT ID: NCT00589823 Completed - Cancers, Pain Clinical Trials

Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Start date: June 2007
Phase: Phase 3
Study type: Interventional

Cancer patients taking regular medication for their pain often still have episodes of severe pain that 'break through' despite their background pain treatment. Fentanyl is a strong, short-acting painkiller often used to treat this 'breakthrough' pain. Nasalfent contains fentanyl in a patented drug delivery system called PecSys and is given via a simple nasal spray. This study will test the efficacy and safety of Nasalfent compared to Immediate Release Morphine Sulphate in the treatment of breakthrough cancer pain.

NCT ID: NCT00458510 Completed - Cancers, Pain Clinical Trials

Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain

Start date: January 2007
Phase: Phase 3
Study type: Interventional

Cancer patients taking regular medication for their pain often still have episodes of severe pain that 'break through' despite their background pain treatment. Fentanyl is a strong, short-acting pain killer often used to treat this 'breakthrough' pain. Nasalfent contains fentanyl in a patented drug delivery system called PecSys and is given via a simple nasal spray. This study will examine the long-term safety of Nasalfent in the treatment of breakthrough cancer pain.

NCT ID: NCT00012896 Completed - Cancers, Pain Clinical Trials

Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines

Start date: n/a
Phase: N/A
Study type: Interventional

Cancer pain is a pervasive problem for the person with cancer. Despite advances in knowledge, effective cancer management is infrequently achieved. While this problem is multi-factorial, the patient may have attitudinal barriers to effective pain management that can be ameliorated with novel interventions.